Redhill biopharma ltd. (RDHL)
Income statement / TTM
Jun'18Jun'17
NET REVENUES

0

0

COST OF REVENUES

0

0

GROSS PROFIT

0

0

RESEARCH AND DEVELOPMENT EXPENSES, net

0

0

SELLING, MARKETING AND BUSINESS DEVELOPMENT EXPENSES

0

0

GENERAL AND ADMINISTRATIVE EXPENSES

0

0

OPERATING LOSS

0

0

FINANCIAL INCOME

0

0

FINANCIAL EXPENSES

0

0

FINANCIAL INCOME (EXPENSES), net

0

0

LOSS AND COMPREHENSIVE LOSS FOR THE PERIOD

0

0

LOSS PER ORDINARY SHARE (U.S. dollars):
Basic and diluted

0.05

0.06

WEIGHTED AVERAGE OF ORDINARY SHARES (in thousands)

213,439,000

171,640,000